APA

Lukashevich V., Schweizer A., Shao Q., Groop P. & Kothny W. (20111207). Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial. : Diabetes, obesity & metabolism.

Chicago

Lukashevich V, Schweizer A, Shao Q, Groop P-H and Kothny W. 20111207. Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial. : Diabetes, obesity & metabolism.

Harvard

Lukashevich V., Schweizer A., Shao Q., Groop P. and Kothny W. (20111207). Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial. : Diabetes, obesity & metabolism.

MLA

Lukashevich V, Schweizer A, Shao Q, Groop P-H and Kothny W. Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial. : Diabetes, obesity & metabolism. 20111207.